Praxis Precision Medicines, Inc. Common Stock (PRAX) Stock Price

PRAXStock

$368.02+654.47%52W

Market Cap$10.28B

P/E—

PEG Ratio—

Div yield—

Beta2.82

PRAX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)0.64%

Price vs S&P 500 (4W)21.36%

VGM Score41.57

Book Value / Share (Quarterly)$48.04

P/TBV (Annual)1.99x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-10.97

Price vs S&P 500 (YTD)12.91%

Net Profit Margin (TTM)-2137.48%

EPS (TTM)$-13.37

10-Day Avg Trading Volume0.38M

EPS Excl Extra (TTM)$-13.37

EPS (Annual)$-13.48

ROI (Annual)-34.54%

Cash / Share (Quarterly)$27.17

ROA (Last FY)-32.33%

EBITD / Share (TTM)$-14.60

ROE (5Y Avg)-120.07%

Operating Margin (TTM)-2340.29%

Cash Flow / Share (Annual)$-9.89

P/B Ratio7.67x

P/B Ratio (Quarterly)6.96x

Net Income / Employee (Annual)$-1,805,200

EV / Revenue (TTM)1147.27x

Net Interest Coverage (TTM)-753.34x

ROA (TTM)-40.22%

EPS Incl Extra (Annual)$-13.48

Current Ratio (Annual)10.22x

Quick Ratio (Quarterly)15.46x

3-Month Avg Trading Volume0.47M

52-Week Price Return654.47%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$48.01

P/S Ratio (Annual)1202.78x

Asset Turnover (Annual)0.02x

52-Week High$392.70

EPS Excl Extra (Annual)$-13.48

26-Week Price Return11.89%

Quick Ratio (Annual)10.03x

13-Week Price Return4.98%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)15.73x

Enterprise Value$9.81B

Asset Turnover (TTM)0.02x

Book Value / Share Growth (5Y)-20.92%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-2137.48%

Cash / Share (Annual)$23.79

3-Month Return Std Dev79.37%

Net Income / Employee (TTM)$-1,943,600

ROE (Last FY)-34.54%

EPS Basic Excl Extra (Annual)$-13.48

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-13.37

ROI (TTM)-43.02%

P/S Ratio (TTM)1202.78x

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$1.54

Price vs S&P 500 (52W)636.16%

Year-to-Date Return24.87%

5-Day Price Return-0.49%

EPS Normalized (Annual)$-13.48

ROA (5Y Avg)-90.66%

Net Profit Margin (Annual)-2137.48%

Month-to-Date Return19.56%

Cash Flow / Share (TTM)$-1.79

EBITD / Share (Annual)$-14.49

Operating Margin (Annual)-2340.29%

ROI (5Y Avg)-120.07%

EPS Basic Excl Extra (TTM)$-13.37

P/TBV (Quarterly)6.96x

P/B Ratio (Annual)8.39x

Pretax Margin (TTM)-2137.48%

Book Value / Share (Annual)$34.85

Price vs S&P 500 (13W)2.19%

Beta2.82x

Revenue / Share (TTM)$0.00

ROE (TTM)-43.02%

52-Week Low$37.19

vGradeF

mGradeB

vgmGradeC

PRAX Earnings Surprise History

Q2 25-3.31est. -3.36

Q3 25-3.36est. -3.49

Q4 25-3.50est. -3.13

Q1 26-3.20est. -3.68

Q2 26-2.87est. -3.69

PRAX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.17

4.16

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$67.01

About Praxis Precision Medicines, Inc. Common Stock

Praxis Precision Medicines is a clinical-stage biopharmaceutical company developing therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. The company leverages two proprietary platforms, Cerebrum and Solidus, to advance a portfolio of four clinical-stage candidates targeting movement disorders and epilepsy, including Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen.